By Chris Wack

iRhythm Technologies Inc. said Friday it received FDA 510(k) clearance for its Zio ECG Utilization Software System for the Zio Watch.

The ZEUS system is produced in partnership with Verily, an Alphabet precision health company.

The ZEUS System is the AI algorithm and solution component of the Zio Watch, a sensor-based wearable for noninvasive, clinical grade, long-term continuous monitoring for atrial fibrillation.

Verily also received FDA 510(k) clearance for the Zio Watch.

iRhythm plans to introduce the ZEUS System for a limited market evaluation in 2023.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

July 22, 2022 08:59 ET (12:59 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Alphabet (NASDAQ:GOOG)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Alphabet.
Alphabet (NASDAQ:GOOG)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Alphabet.